Azora Therapeutics Stock (NASDAQ:AZR)
Previous Close
$4.15
52W Range
$1.31 - $8.75
50D Avg
$4.62
200D Avg
$3.21
Market Cap
$10.63M
Avg Vol (3M)
$56.71K
Beta
1.64
Div Yield
-
AZR Company Profile
Azora Therapeutics is a biopharmaceutical company developing treatments for serious inflammatory diseases. Its lead program, AT177, is an oral, colon-targeted aryl hydrocarbon receptor agonist in development for ulcerative colitis.